Featured Editorial

1. The High Cost Of Zero Waste: Protecting Patients In Clinical Supply 2/20/2026

   Zero-waste clinical supply models may protect margins, but at what cost to patients and data integrity? Lean trials shift risk in ways sponsors cannot afford to ignore.

2. From Crisis Response To Repeatable Resilience In Clinical Supply 2/19/2026

   Clinical trial supply chains face constant disruption. Embedding resilience and transparency into daily operations ensures continuity, safety, and reliability.

3. Transitioning Into A Clinical Trial Supply Chain Study Lead Role 2/18/2026

   Stepping into a clinical trial supply lead role demands ownership, risk foresight, and agile forecasting to keep investigational product moving and patients on track.

4. U.S. Pharma Tariffs And MFN In 2026: Manufacturing And Procurement Impact 2/18/2026

   Beroe Inc.'s Mathini Ilancheran discusses the 2025 U.S. pharma tariff framework and translates it into actionable procurement and outsourcing responses.

5. Beyond The AI Hype: Prompt Engineering In Clinical Trial Supply 2/17/2026

   AI is useful in clinical trial supply only if it reduces risk, not adds it. Explore structured prompting frameworks that strengthen deviation handling and disruption response.

6. Active Versus Passive Shipping Solutions For Clinical Shipments 2/13/2026

   Explore active and passive temperature-controlled shipping solutions and their impact on clinical trial supply, balancing cost, risk, and product integrity.

7. Managing Risk And Resilience In Clinical Trial Supply And Operations 2/12/2026

   Clinical leaders are shifting from reactive fixes to deliberate governance and early decision-making to sustain trial continuity under persistent operational uncertainty.

8. FDA Staffing Constraints And Operational Risk In Clinical Supply 2/11/2026

   FDA staffing shortages and supply pressures are reshaping clinical trials, requiring closer coordination across regulatory, manufacturing, and operations.

9. Tariffs Threaten Clinical Trial Supply Chains: Preparing For Volatility 2/10/2026

   Tariffs and FDA staffing gaps are quietly reshaping clinical trial supply chains. From comparators to customs delays, these forces are creating real risk for timelines, budgets, and patients.

10. The Key Role Of Clinical Supply Teams In Patient Centricity Efforts 2/9/2026

    Clinical supply decisions shape patient access, safety, and trial success. From logistics to procurement, patient-centric supply can accelerate therapies or quietly delay them.